KF
UTHR icon

Krilogy Financial’s United Therapeutics UTHR Stock Holding History

Krilogy Financial’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$818K Sell
1,510
-78
-5% -$43.9K 0.02% 456
2026
Q1 		$922K Sell
1,588
-165
-9% -$82.2K 0.03% 396
2025
Q4 		$830K Buy
1,753
+712
+68% +$332K 0.03% 400
2025
Q3 		$466K Buy
+1,041
New +$350K 0.02% 541

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Krilogy Financial's UTHR Position: Q2 2026 in Review

Krilogy Financial reduced its United Therapeutics (UTHR) stake by 4.9% in Q2 2026, selling an estimated $43.9K and leaving 1,510 shares worth $818K. The position accounts for 0.02% of the portfolio, ranked #456.

Krilogy Financial first reported a position in UTHR in Q3 2025 and has held it in 4 quarters since. The position peaked at $922K in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Krilogy Financial held 1,510 shares of United Therapeutics worth $818K as of Q2 2026.
  • Krilogy Financial sold 78 United Therapeutics shares in Q2 2026, an estimated $43.9K.
  • United Therapeutics made up 0.02% of Krilogy Financial's portfolio in Q2 2026, its #456 holding.
  • Krilogy Financial first reported a position in United Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Krilogy Financial's United Therapeutics position peaked at $922K in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.